Literature DB >> 35236956

Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome.

Jacqueline-Marie N Ferland1, Randall J Ellis1, Gregory Rompala1, Joseph A Landry1, James E Callens1, Annie Ly1, Micah D Frier1, Teddy O Uzamere1, Yasmin L Hurd2.   

Abstract

Despite the belief that cannabis is relatively harmless, exposure during adolescence is associated with increased risk of developing several psychopathologies in adulthood. In addition to the high levels of use amongst teenagers, the potency of ∆-9-tetrahydrocannabinol (THC) has increased more than fourfold compared to even twenty years ago, and it is unclear whether potency influences the presentation of THC-induced behaviors. Expanded knowledge about the impact of adolescent THC exposure, especially high dose, is important to delineating neural networks and molecular mechanisms underlying psychiatric risk. Here, we observed that repeated exposure to low (1.5 mg/kg) and high (5 mg/kg) doses of THC during adolescence in male rats produced divergent effects on behavior in adulthood. Whereas low dose rats showed greater sensitivity to reward devaluation and also self-administered more heroin, high dose animals were significantly more reactive to social isolation stress. RNA sequencing of the basolateral amygdala, a region linked to reward processing and stress, revealed significant perturbations in transcripts and gene networks related to synaptic plasticity and HPA axis that were distinct to THC dose as well as stress. In silico single-cell deconvolution of the RNAseq data revealed a significant reduction of astrocyte-specific genes related to glutamate regulation in stressed high dose animals, a result paired anatomically with greater astrocyte-to-neuron ratios and hypotrophic astrocytes. These findings emphasize the importance of dose and behavioral state on the presentation of THC-related behavioral phenotypes in adulthood and dysregulation of astrocytes as an interface for the protracted effects of high dose THC and subsequent stress sensitivity.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35236956     DOI: 10.1038/s41380-022-01467-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  80 in total

1.  Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.

Authors:  Erica Zamberletti; Sarah Beggiato; Luca Steardo; Pamela Prini; Tiziana Antonelli; Luca Ferraro; Tiziana Rubino; Daniela Parolaro
Journal:  Neurobiol Dis       Date:  2013-11-04       Impact factor: 5.996

2.  Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats.

Authors:  Serena Stopponi; Laura Soverchia; Massimo Ubaldi; Andrea Cippitelli; Giovanni Serpelloni; Roberto Ciccocioppo
Journal:  Eur Neuropsychopharmacol       Date:  2013-12-24       Impact factor: 4.600

3.  Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats.

Authors:  Maria Ellgren; Sabrina M Spano; Yasmin L Hurd
Journal:  Neuropsychopharmacology       Date:  2006-07-05       Impact factor: 7.853

4.  Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood.

Authors:  Andrew R Abela; Arya Rahbarnia; Suzanne Wood; Anh D Lê; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2019-01-29       Impact factor: 4.530

5.  Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex.

Authors:  Justine Renard; Laura G Rosen; Michael Loureiro; Cleusa De Oliveira; Susanne Schmid; Walter J Rushlow; Steven R Laviolette
Journal:  Cereb Cortex       Date:  2017-02-01       Impact factor: 5.357

6.  Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.

Authors:  Tiziana Rubino; Daniela Vigano'; Natalia Realini; Cinzia Guidali; Daniela Braida; Valeria Capurro; Chiara Castiglioni; Francesca Cherubino; Patrizia Romualdi; Sanzio Candeletti; Mariaelvina Sala; Daniela Parolaro
Journal:  Neuropsychopharmacology       Date:  2008-01-02       Impact factor: 7.853

7.  Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.

Authors:  Tiziana Rubino; Natalia Realini; Daniela Braida; Sandra Guidi; Valeria Capurro; Daniela Viganò; Cinzia Guidali; Marta Pinter; Mariaelvina Sala; Renata Bartesaghi; Daniela Parolaro
Journal:  Hippocampus       Date:  2009-08       Impact factor: 3.899

Review 8.  Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.

Authors:  Justine Renard; Marie-Odile Krebs; Gwenaëlle Le Pen; Thérèse M Jay
Journal:  Front Neurosci       Date:  2014-11-10       Impact factor: 4.677

9.  Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.

Authors:  Alvaro Llorente-Berzal; Emma Puighermanal; Aurelijus Burokas; Andrés Ozaita; Rafael Maldonado; Eva M Marco; Maria-Paz Viveros
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

10.  Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.

Authors:  Justine Renard; Hanna J Szkudlarek; Cecilia P Kramar; Christina E L Jobson; Kyra Moura; Walter J Rushlow; Steven R Laviolette
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more
  1 in total

1.  Chronic adolescent exposure to cannabis in mice leads to sex-biased changes in gene expression networks across brain regions.

Authors:  Yanning Zuo; Attilio Iemolo; Patricia Montilla-Perez; Hai-Ri Li; Xia Yang; Francesca Telese
Journal:  Neuropsychopharmacology       Date:  2022-08-22       Impact factor: 8.294

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.